NASDAQ:COLL

Collegium Pharmaceutical News Headlines

$19.83
+0.16 (+0.81 %)
(As of 09/17/2021 04:00 PM ET)
Add
Compare
Today's Range
$19.48
$19.88
50-Day Range
$17.75
$25.39
52-Week Range
$17.24
$26.91
Volume531,119 shs
Average Volume208,861 shs
Market Capitalization$705.15 million
P/E Ratio7.29
Dividend YieldN/A
Beta0.89

Media Mentions By Week

Collegium Pharmaceutical Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

COLL
News Sentiment

0.46

0.30

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

COLL Articles
This Week

3

1

COLL Articles
Average Week

Get Collegium Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter.

Collegium Pharmaceutical (NASDAQ COLL) News Headlines Today

SourceHeadline
Collegium Pharmaceutical (NASDAQ:COLL) Coverage Initiated by Analysts at Needham & Company LLCCollegium Pharmaceutical (NASDAQ:COLL) Coverage Initiated by Analysts at Needham & Company LLC
americanbankingnews.com - September 18 at 1:58 PM
Collegium Announces Four Posters Presented at PAINWeek 2021 National ConferenceCollegium Announces Four Posters Presented at PAINWeek 2021 National Conference
finance.yahoo.com - September 13 at 11:48 AM
Needham & Company LLC Begins Coverage on Collegium Pharmaceutical (NASDAQ:COLL)Needham & Company LLC Begins Coverage on Collegium Pharmaceutical (NASDAQ:COLL)
americanbankingnews.com - September 11 at 12:04 PM
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Quarterly Sales of $84.78 MillionCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Quarterly Sales of $84.78 Million
americanbankingnews.com - September 6 at 4:58 AM
 Brokerages Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Will Announce Earnings of $0.35 Per Share Brokerages Anticipate Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Will Announce Earnings of $0.35 Per Share
americanbankingnews.com - September 4 at 3:14 AM
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Sees Large Decrease in Short InterestCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Sees Large Decrease in Short Interest
americanbankingnews.com - September 2 at 11:12 AM
Collegium Pharmaceutical (NASDAQ:COLL) Coverage Initiated at Needham & Company LLCCollegium Pharmaceutical (NASDAQ:COLL) Coverage Initiated at Needham & Company LLC
americanbankingnews.com - August 28 at 1:52 PM
Collegium Pharmaceutical Authorizes $100M Share Buyback ProgramCollegium Pharmaceutical Authorizes $100M Share Buyback Program
marketwatch.com - August 16 at 4:44 PM
Collegium Pharmaceutical Up 12% After Buyback ProgramCollegium Pharmaceutical Up 12% After Buyback Program
marketwatch.com - August 16 at 4:44 PM
Collegium Announces $100 Million Share Repurchase ProgramCollegium Announces $100 Million Share Repurchase Program
finance.yahoo.com - August 16 at 8:39 AM
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Delivered A Better ROE Than Its IndustryCollegium Pharmaceutical, Inc. (NASDAQ:COLL) Delivered A Better ROE Than Its Industry
nasdaq.com - August 10 at 8:46 AM
Collegium Stock Is Getting Beaten As Q2 Earnings Miss Street Estimates; Revises FY21 GuidanceCollegium Stock Is Getting Beaten As Q2 Earnings Miss Street Estimates; Revises FY21 Guidance
markets.businessinsider.com - August 6 at 5:26 PM
Collegium Pharmaceutical, inc (COLL) Q2 2021 Earnings Call TranscriptCollegium Pharmaceutical, inc (COLL) Q2 2021 Earnings Call Transcript
finance.yahoo.com - August 6 at 12:26 PM
Collegium Pharmaceutical, Inc. 2021 Q2 - Results - Earnings Call PresentationCollegium Pharmaceutical, Inc. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 6 at 10:59 AM
Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 MillionCollegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million
finance.yahoo.com - August 5 at 8:34 PM
Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Miss EstimatesCollegium Pharmaceutical (COLL) Q2 Earnings and Revenues Miss Estimates
finance.yahoo.com - August 5 at 8:34 PM
Is Collegium Pharmaceutical, Inc.s (NASDAQ:COLL) ROE Of 25% Impressive?Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?
finance.yahoo.com - August 4 at 12:36 PM
What Wall Street expects from Collegium Pharmaceuticals earningsWhat Wall Street expects from Collegium Pharmaceutical's earnings
markets.businessinsider.com - August 3 at 4:30 PM
Ribon Therapeutics Appoints Paul Brannelly as Chief Financial OfficerRibon Therapeutics Appoints Paul Brannelly as Chief Financial Officer
businesswire.com - June 28 at 8:42 AM
Collegium Announces Publication of Real-World Data in Journal of Pain ResearchCollegium Announces Publication of Real-World Data in Journal of Pain Research
finance.yahoo.com - June 16 at 5:59 PM
Collegium Pharmaceutical, Inc. Common Stock (COLL)Collegium Pharmaceutical, Inc. Common Stock (COLL)
nasdaq.com - June 16 at 2:57 AM
Under Bidens Budget, These 2 Little-Known Biotechs Could Help End the Opioid CrisisUnder Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid Crisis
finance.yahoo.com - June 10 at 2:57 AM
Collegium Pharmaceutical (COLL) Beats Q1 Earnings and Revenue EstimatesCollegium Pharmaceutical (COLL) Beats Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 6 at 11:11 PM
Collegium Pharmaceutical Inc (COLL) Q1 2021 Earnings Call TranscriptCollegium Pharmaceutical Inc (COLL) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 6 at 11:11 PM
Collegium Reports Record Quarterly Revenue of $87.7 MillionCollegium Reports Record Quarterly Revenue of $87.7 Million
finance.yahoo.com - May 6 at 6:11 PM
If You Had Bought Collegium Pharmaceutical (NASDAQ:COLL) Stock Five Years Ago, You Could Pocket A 47% Gain TodayIf You Had Bought Collegium Pharmaceutical (NASDAQ:COLL) Stock Five Years Ago, You Could Pocket A 47% Gain Today
finance.yahoo.com - May 6 at 1:11 PM
COLL: What does Argus have to say about COLL?COLL: What does Argus have to say about COLL?
finance.yahoo.com - April 29 at 11:10 PM
Collegium Pharmaceutical (COLL) Reports Next Week: Wall Street Expects Earnings GrowthCollegium Pharmaceutical (COLL) Reports Next Week: Wall Street Expects Earnings Growth
finance.yahoo.com - April 29 at 6:09 PM
Collegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate UpdateCollegium to Host Conference Call to Discuss First Quarter 2021 Financial Results and Provide Corporate Update
finance.yahoo.com - April 15 at 6:55 PM
Does Collegium Pharmaceutical (NASDAQ:COLL) Have A Healthy Balance Sheet?Does Collegium Pharmaceutical (NASDAQ:COLL) Have A Healthy Balance Sheet?
nasdaq.com - April 12 at 8:03 PM
Collegium Pharmaceutical Inc (COLL) Q4 2020 Earnings Call TranscriptCollegium Pharmaceutical Inc (COLL) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 26 at 8:21 AM
Collegium Reports Record Full-Year 2020 Revenue of $310.0 MillionCollegium Reports Record Full-Year 2020 Revenue of $310.0 Million
finance.yahoo.com - February 25 at 5:17 PM
Collegium Pharmaceuticals Earnings OutlookCollegium Pharmaceutical's Earnings Outlook
finance.yahoo.com - February 24 at 1:37 PM
Collegium Pharmaceutical earnings preview: what to expectCollegium Pharmaceutical earnings preview: what to expect
markets.businessinsider.com - February 23 at 9:35 AM
Collegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate UpdateCollegium to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - February 11 at 6:14 PM
Collegium Pharmaceutical wants to usher in a wave of non-opioid pain solutionsCollegium Pharmaceutical wants to 'usher in a wave of non-opioid pain solutions'
bizjournals.com - February 11 at 1:13 PM
Monolithic Power Systems To Replace TechnipFMC In S&P 500 : S&P Dow Jones IndicesMonolithic Power Systems To Replace TechnipFMC In S&P 500 : S&P Dow Jones Indices
nasdaq.com - February 8 at 10:16 PM
Collegium Pharmaceutical Inc BuyCollegium Pharmaceutical Inc Buy
markets.businessinsider.com - January 20 at 9:26 PM
Collegium Provides 2021 Financial GuidanceCollegium Provides 2021 Financial Guidance
finance.yahoo.com - January 6 at 6:21 PM
Is COLL A Good Stock To Buy Now?Is COLL A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 10:31 PM
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q3 2020 Results - Earnings Call TranscriptCollegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 12:17 PM
Collegium Pharmaceutical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsCollegium Pharmaceutical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
nasdaq.com - November 7 at 10:26 AM
Results: Collegium Pharmaceutical, Inc. Beat Earnings Expectations And Analysts Now Have New ForecastsResults: Collegium Pharmaceutical, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
finance.yahoo.com - November 7 at 10:25 AM
Collegium Pharmaceutical (COLL) Tops Q3 Earnings and Revenue EstimatesCollegium Pharmaceutical (COLL) Tops Q3 Earnings and Revenue Estimates
finance.yahoo.com - November 5 at 10:48 PM
Collegium Pharmaceutical EPS beats by $0.13, beats on revenueCollegium Pharmaceutical EPS beats by $0.13, beats on revenue
seekingalpha.com - November 5 at 5:48 PM
Collegium Pharmaceutical, Inc. to Host Earnings CallCollegium Pharmaceutical, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 5:48 PM
Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020
finance.yahoo.com - November 5 at 5:48 PM
Can You Imagine How Collegium Pharmaceutical's (NASDAQ:COLL) Shareholders Feel About The 51% Share Price Increase?Can You Imagine How Collegium Pharmaceutical's (NASDAQ:COLL) Shareholders Feel About The 51% Share Price Increase?
finance.yahoo.com - November 5 at 7:29 AM
Collegium Pharmaceutical Q3 2020 Earnings PreviewCollegium Pharmaceutical Q3 2020 Earnings Preview
seekingalpha.com - November 4 at 3:09 PM
Collegium Announces Publication of “Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza® ER” in Pain MedicineCollegium Announces Publication of “Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza® ER” in Pain Medicine
finance.yahoo.com - October 26 at 12:24 PM
Get Collegium Pharmaceutical News Delivered to You Automatically

Sign up to receive the latest news and ratings for COLL and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.